Each year, RSV infections send up to 80,000 kids under 5 to the hospital for emergency treatment. A new antibody treatment could protect the youngest kids — newborns and up infants up to 2 years old. Christoph Soeder/dpa/picture alliance via Getty I hide caption
People pass a COVID-19 testing site on a Manhattan street on Jan. 21. The White House says it is running out of money to pay for coronavirus tests for people who don't have insurance. Spencer Platt/Getty Images hide caption
A temporary tent was set up at UMass Memorial Hospital in Worcester, Mass., to prepare for an uptick in COVID-19 cases this month. Erin Clark/Boston Globe via Getty Images hide caption
Ben Carson, here in June, posted about his recovery from COVID-19 on Facebook on Friday. Evan Vucci/AP hide caption
The Food and Drug Administration has authorized Eli Lilly's antibody-based drug bamlanivimab for emergency use as a treatment for COVID-19. Eli Lilly via AP hide caption
An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. David Morrison/AP hide caption
In this photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, Ind. On Monday, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it is unlikely to help. David Morrison/AP hide caption